Published in Medical Device Business Week, September 9th, 2009
"with node-negative disease were randomly selected from the years 2000 and 2001. The primary end point was disease-free survival. We identified 856 patients with node-negative disease who had not received systemic adjuvant therapy ( the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.